DMD and Duchenne muscular dystrophy: The knowledge of dystrophin patho-physio mechanisms and the synthesis of new molecules and delivery systems (nanomaterials) that overcome the stability, degradation and target specificity problems will allow the development of novel drugs for a promising DMD therapy.